TrialCancer2025

Cladribine, idarubicin, and cytarabine (CLIA) for patients with relapsed and/or refractory acute myeloid leukemia: A single-center, single-arm, phase 2 trial.

Hannah Goulart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.